CBS New York Amplifies Ovarian Cancer Prevention Message
OCRA’s President & CEO, Audra Moran, spoke with CBS New York about the newest ovarian cancer risk and prevention updates, in an important segment timed to Ovarian Cancer Awareness Month.
News
The Washington Post Publishes Article Highlighting Proven Ovarian Cancer Prevention Method
An article published on February 2nd in The Washington Post highlights a turning point in our fight against ovarian cancer. As covered in the article, “Fallopian tube removal advised for more women to prevent ovarian cancer,” OCRA released a consensus statement, endorsed by the Society of Gynecologic Oncology, encouraging an aggressive prevention strategy: removal of the fallopian … Continued
The New York Times Publishes Article Highlighting Risk and Prevention
An article published on February 1st in The New York Times highlights a turning point in our fight against ovarian cancer. As covered in the article, “To Prevent Cancer, More Women Should Consider Removing Fallopian Tubes, Experts Say,” OCRA is launching an important campaign centered around two messages with proven outcomes: knowing one’s risk, and … Continued
A Turning Point in Ovarian Cancer Prevention
Today marks a turning point in our fight against ovarian cancer. As covered in The New York Times, we are launching an important campaign centered around two messages with proven outcomes: knowing one’s risk, and taking preventative action. You know better than anyone the challenges we face in the fight against ovarian cancer. There’s no … Continued
Ovarian Cancer Leaders Urge Genetic Testing For Increased-Risk Individuals, and Consideration of Prophylactic Surgery for All Women
[NEW YORK, Feb. 1, 2023] — In a dramatic shift of focus in the fight against ovarian cancer, Ovarian Cancer Research Alliance (OCRA), the world’s leading ovarian cancer organization, today announced they will begin a nationwide push for genetic testing of those at increased risk and consideration of a prophylactic surgery even for those at average risk to potentially … Continued
Ovarian Cancer Screening and Symptom Awareness Consensus Statement
Finding a method of early detection for ovarian cancer has been a primary focus of research for years, and was believed to be a promising approach to stopping women, or anyone born with ovaries, from dying of the disease. Some other cancers have demonstrated that earlier stage diagnoses can lead to better prognoses, and an oft-cited … Continued
OCRA Awards Rosalind Franklin and Liz Tilberis Research Prizes for 2022
OCRA is pleased to award research prizes to Dr. Ursula Matulonis and Dr. Pradeep Chaluvally-Raghavan, two investigators doing groundbreaking and important work in the field of ovarian cancer research. OCRA’s research prize recipients are selected by members of OCRA’s Scientific Advisory Committee. These prizes were awarded in December 2022. Dr. Ursula Matulonis Awarded Rosalind Franklin … Continued
Three Ways to Support OCRA in ’23 … in 20 Minutes or Less
Many people talk about New Year’s resolutions in the month of January, which is all well and good. But sometimes these long-range goals don’t exactly stick. Why not focus on simple actions you can take right now? Here are three things you can do in 2023 that will have a huge impact on OCRA, and … Continued
OCRA-Funded Study Reveals Role of L1CAM in Development and Spread of HGSOC
A recent study, funded in part by OCRA, has shed new light on how the most common subtype of ovarian cancer develops and metastasizes, by identifying a key molecule that allows malignancies in the fallopian tube to migrate to the ovaries and continue to grow. High-grade serous ovarian carcinoma (HGSOC) is the most common subtype … Continued
OCRA-Funded Research Sheds Light On Ovarian Cancer Resistance to Immunotherapy
As immunotherapies have seen rising success in treating several other cancers, researchers are hard at work uncovering why immunotherapy for ovarian cancer has, so far, proven ineffective. In a study published in Nature, a research team at Memorial Sloan Kettering Cancer Center set out to identify specific factors that lead to immune evasion in high-grade … Continued
Melica Brodeur, MD, MSc | Meet a Scientist
Dr. Melica Brodeur, of Memorial Sloan Kettering Cancer Center, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Exploiting SMARCA4 Alterations for New Therapeutics in Ovarian Cancer,” Dr. Brodeur is investigating a genetic mutation, found in more than half of ovarian cancers, that is associated with relatively high presence of active immune … Continued
2022 Breakthroughs in Ovarian Cancer Research and Treatment
“We are truly in the Golden Age, the Renaissance, if you will, of care for people with ovarian cancer. So much is happening.” Dr. Stephanie Blank Though there is still much progress to be made when it comes to ovarian cancer therapies, breakthroughs in recent years have led to significant changes in how the disease … Continued